Small Molecule Inhibitors of Histone Arginine Methyltransferases:  Homology Modeling, Molecular Docking, Binding Mode Analysis, and Biological Evaluations

Journal of Medicinal Chemistry
2007.0

Abstract

The screening of the inhibition capabilities of dye-like small molecules from a focused library against both human PRMT1 and Aspergillus nidulans RmtA is reported as well as molecular modeling studies (homology modeling, molecular docking, and 3-D QSAR) of the catalytic domain of the PRMT1 fungal homologue RmtA. The good correlation between computational and biological results makes RmtA a reliable tool for screening arginine methyltransferase inhibitors. In addition, the binding mode analyses of tested derivatives reveal the crucial role of two regions, the pocket formed by Ile12, His13, Met16, and Thr49 and the SAM cisteinic binding site subsite. These regions should be taken into account in the design of novel PRMT inhibitors.

Knowledge Graph

Similar Paper

Small Molecule Inhibitors of Histone Arginine Methyltransferases:  Homology Modeling, Molecular Docking, Binding Mode Analysis, and Biological Evaluations
Journal of Medicinal Chemistry 2007.0
Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling
Bioorganic & Medicinal Chemistry Letters 2017.0
Discovery and Mechanistic Study of a Class of Protein Arginine Methylation Inhibitors
Journal of Medicinal Chemistry 2010.0
Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations
Bioorganic & Medicinal Chemistry Letters 2018.0
Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Discovery of decamidine as a new and potent PRMT1 inhibitor
MedChemComm 2017.0
Exploration of Cyanine Compounds as Selective Inhibitors of Protein Arginine Methyltransferases: Synthesis and Biological Evaluation
Journal of Medicinal Chemistry 2015.0
Discovery and structure–activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors
Bioorganic & Medicinal Chemistry Letters 2015.0
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach
Journal of Medicinal Chemistry 2022.0